Good manufacturing practice for clinical practice of new anticancer drugs (conventional vs new generation dosage form i.e Stem cell-based)

Mohamed, Farahidah (2022) Good manufacturing practice for clinical practice of new anticancer drugs (conventional vs new generation dosage form i.e Stem cell-based). In: Wahid Hasyim Conference on Advance Pharmaceutical Sciences, 5-6 June 2022, Semarang, Indonesia. (Unpublished)

Preview	PDF - Supplemental Material Download (335kB) | Preview
Preview	PDF - Supplemental Material Download (2MB) | Preview
Preview	PDF (Presentation) - Presentation Download (2MB) | Preview

Item Type:	Conference or Workshop Item (Slide Presentation)
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy
Depositing User:	Assoc Prof Farahidah Mohamed
Date Deposited:	07 Jul 2022 17:20
Last Modified:	07 Jul 2022 17:20
URI:	http://irep.iium.edu.my/id/eprint/98666

Actions (login required)

View Item